Safety concerns included a 58% rate of treatment-related adverse events, with severe cases like immune-related colitis and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback